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Abstract:  N,N-Didesmethylgrossularine-1 (DDMG-1), a compound with a rare   
α-carboline structure, was isolated from an Indonesian ascidian Polycarpa aurata as 
responsible for the observed inhibitory activity against TNF-α production in 
lipopolysaccharide-stimulated murine macrophage-like RAW264.7 cells. DDMG-1 
inhibited the mRNA level of mTNF-α, IκB-α degradation, and binding of NF-κB to the 
target DNA site in LPS-stimulated RAW 264.7 cells. Moreover, DDMG-1 had an 
inhibitory effect on the production of IL-8, which is produced in CD14
+-THP-1 cells 
stimulated by LPS. DDMG-1 is thus a promising drug candidate lead compound for the 
treatment of chronic inflammatory diseases, such as rheumatoid arthritis. 
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1. Introduction  
 
Macrophages play an important role in immune reactions, allergy and inflammation [1]. By 
releasing many different kinds of cytokines, these cells induce inflammatory reactions, as well as 
initiate and maintain specific immune responses. Lipopolysaccharide (LPS), a component of the gram-
negative bacterial cell wall, is frequently used as an inflammatory model due to its ability to activate 
macrophages [2]. In response to microbes and their products such as LPS, macrophages secrete various 
inflammatory cytokines including interleukin-1 (IL-1), IL-6, chemokines including IL-8, and tumor 
necrosis factor-α (TNF-α) through the activation of NF-κB [3]. In the case of cancer cachexia, 
inflammatory cytokines such as IL-6 and TNF-α are considered to be involved, and these cytokines 
are most likely released from macrophages. In rheumatoid arthritis, a variety of cell populations 
including macrophages infiltrate the tissue in large numbers, and a range of proinflammatory cytokines 
are produced abundantly by them. Actually, the generation of CD14-positive macrophage precursors is 
increased in rheumatoid arthritis [4]. Therefore, the modulation of macrophage-mediated inflammatory 
responses is important in order to formulate a new therapeutic approach against these inflammatory 
diseases. In the search for new anti-TNF-α substances, we found that the EtOH extract of an 
Indonesian ascidian, Polycarpa aurata, reduced the production of TNF-α from LPS-stimulated murine 
macrophage-like RAW264.7 cells. Bioassay-guided isolation yielded N,N-didesmethylgrossularine-1 
(DDMG-1, Figure 1) as an active compound. In the present study, we describe the isolation and 
biological activity of DDMG-1. 
 
Figure 1. Structure of N,N-didesmethylgrossularine-1 (DDMG-1). 
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2. Results and Discussion  
 
2.1. Confirmation of DDMG-1 
 
DDMG-1 was obtained as a yellow pigment from P. aurata collected from a coral reef in the 
Lembeh Strait, North Sulawesi, Indonesia. The EI mass spectrum of DDMG-1 showed a molecular ion Mar. Drugs 2009, 7                                    
 
 
591
at m/z 366, and the molecular formula C21H14N6O was deduced from EIMS and NMR spectra. The 
1H- 
NMR spectrum of DDMG-1 revealed the presence of nine aromatic protons, and a 3-substituted indole 
moiety that was assigned based on the characteristic signals at δ 9.34 (H-2’), 8.47 (H-4’), 7.48 (H-7’), 
and 7.23 (H-5’ and 6’). The remaining signals were ascribed to four hydrogen atoms on another indole  
(α-carboline) moiety.  
1H- and 
13C-NMR data suggested that this compound is an α-carboline alkaloid possessing an 
indole ring as a side chain. A literature search yielded the structure of DDMG-1 as a candidate, and 
this structure was confirmed by comparing the 
13C-NMR data with the reported values [5] and 
1H- and 
13C-NMR spectra with the Supplemental Information provided in a report on the synthesis of DDMG-1 
and grossularine-1 [6]. Since DDMG-1 has a unique α-carboline structure and considering the fact that 
this was the first study to identify the anti-TNF-α activity of α-carboline alkaloids, the biological 
activity of DDMG-1 in the production of murine and human inflammatory cytokines was further 
studied. 
 
Figure 2. Effects of DDMG-1 on mTNF-α and mIL-6 production and cell proliferation 
induced by LPS-stimulated RAW 264.7 cells. (a) Effects of DDMG-1 on mTNF-α and 
mIL-6 production by LPS-stimulated or non-stimulated RAW264.7 cells. RAW 264.7 cells 
(1 × 10
6 cells/mL) were untreated or treated with LPS (1 μg/mL) with the indicated 
concentrations of DDMG-1 for 24 h, and mTNF-α and mIL-6 levels in the culture 
supernatant were measured by ELISA, as described in Materials and Methods. This 
experiment was repeated three times on different days. Figures were created based on the 
results. *p < 0.05 vs. Control; 
#p < 0.05 vs. LPS. (b) Effects of DDMG-1 on cell 
proliferation. The MTT assay and LDH data were obtained as described in Materials and 
Methods. Data are the means relative (%) to the control value. 
 
 
2.2. DDMG-1 inhibited LPS-induced mTNF-α and mIL-6 production in RAW 264.7 cells 
 
mTNF-α and mIL-6 concentrations in the culture supernatants under each experimental condition in 
LPS-stimulated RAW 264.7 cells were determined by ELISA. RAW 264.7 cells in an unstimulated 
state released 0.4 ng/mL TNF-α into the culture media during incubation for 24 h, whereas the cells 
showed marked TNF-α production on exposure to LPS alone (Figure 2a). DDMG-1 inhibited   Mar. Drugs 2009, 7                                    
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LPS-induced TNF-α production in a dose-dependent manner (Figure 2a). RAW 264.7 cells in a normal 
state released 90 pg/mL mIL-6 into the culture medium during incubation for 24 h, whereas the cells 
showed a marked increase in mIL-6 production up to 410 pg/mL upon exposure to LPS alone   
(Figure 2a). DDMG-1 inhibited LPS-induced mIL-6 production in a dose-dependent manner   
(Figure 2a). In order to elucidate whether DDMG-1 at effective concentrations showed toxicity against 
RAW 264.7 cells, we employed the MTT and LDH methods. The decreased MTT value reflects 
cytotoxicity and the inhibitory effect on cell proliferation. However, these cannot be distinguished. We 
detected cytotoxicity using LDH assays. Data on LDH assay were showed to Figure 2b. The results 
indicated that the inhibiton of TNF-α production by DDMG-1 was not attributable to its nonspecific 
cell toxicity (Figure 2b). Because the production of TNF-α was greater than that of mIL-6 under  
LPS-stimulated conditions, we subsequently planned to use a TNF-α production system. 
 
Figure 3. Effects of DDMG-1 on intracellular signaling molecules in LPS-stimulated 
RAW 264.7 cells. (a) Effect of DDMG-1 on the LPS-induced synthesis of TNF-α 
transcripts. RAW 264.7 cells were pretreated with DDMG-1 for 1 h and stimulated with 
LPS for 4 hr. Total cellular RNA was subjected to real-time PCR. The relative ratio as a 
percentage is also shown, whereby the TNF-α signal was normalized to the GAPDH 
signal. We conducted two independent experiments and graphically presented the results 
separately (□, ■). (b) Effects of DDMG-1 on NF-κB transcription by IκB-α degradation. 
Western blotting of RAW 264.7 cells treated with LPS and DDMG-1, as indicated. Total 
proteins were extracted at the indicated times, resolved by 10% SDS-PAGE, blotted, and 
examined by Western blotting using polyclonal anti-serum against IκB-α. (c) Effects of 
DDMG-1 on the DNA-binding activities of NF-κB and AP-1 transcription factors. RAW 
264.7 cells were treated with LPS and DDMG-1 as indicated, followed by nuclear 
extraction. EMSA was performed as described in Materials and Methods using 
32P-labeled 
probes that possessed NF-κB- and AP-1-binding sites. The NF-κB/probe and AP-1/probe 
complex are indicated. 
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2.3. DDMG-1 down-regulated TNF-a mRNA expression at the transcriptional level 
 
To clarify whether DDMG-1 affects TNF-α expression, semiquantitative RT-PCR was carried out 
using the total RNA of LPS-stimulated RAW 264.7 cells. TNF-α mRNA expression markedly 
increased when cells were simulated with LPS alone. Within 24 h after LPS stimulation, the highest 
expression was observed at 4 h. Thus, the effect of DDMG-1 on TNF-α expression was examined at 4 h. 
The results are shown in Figure 3a. Since two independent experiments showed the almost same results 
and the significant difference was observed between control and test experiments, third experiment 
was not performed and the data of two experiments are shown in Figure 3a. DDMG-1 attenuated the 
LPS-induced synthesis of TNF-α mRNA expression in a dose-dependent manner; however, levels of 
housekeeping GAPDH transcripts remained unchanged on the treatment of RAW 264.7 cells with LPS 
and/or DDMG-1. The above results indicate that DDMG-1 inhibited TNF-α production at the mRNA 
level in LPS-stimulated RAW 264.7 cells. 
 
2.4. DDMG-1 inhibited IκB-α degradation in LPS-stimulated RAW 264.7 cells 
 
To investigate whether the inhibitory action of DDMG-1 is attributable to its sequential effect on 
IκBα degradation, Western blot analysis was carried out with cytoplasmic extracts of LPS-stimulated 
RAW 264.7 cells. Upon exposure to LPS alone, cellular IκBα was markedly degraded at 15 min 
(Figure 3b). DDMG-1 showed a significant inhibitory effect on LPS-induced IκB-α degradation in the 
time-course study (Figure 3b). Moreover, we examined the effects of DDMG-1 on MAPK activation 
in LPS-stimulated RAW 264.7 cells, but DDMG-1 did not affect MAPK activation (data not shown). 
 
2.5. DDMG-1 inhibited LPS-stimulated binding of NF-κB to DNA 
 
DDMG-1 showed a significant inhibitory effect on LPS-induced IκBα degradation in the time-
course study; therefore, it is expected that DDMG-1 inhibits the LPS-stimulated binding of NF-κB to 
target DNA. EMSA was performed using the nuclear extract, and inhibition was observed as expected  
(Figure 3c). The results indicated that DDMG-1 specifically inhibited the binding of NF-κB to the 
target DNA site. 
 
2.6. DDMG-1 inhibited LPS-induced hTNF-α hIL-1b, hIL-6, and IL-8 production in CD14
+-THP-1 
cells 
 
As DDMG-1 inhibited mTNF-α and mIL-6 production in LPS-stimulated RAW 264.7 cells, we 
examined whether DDMG-1 inhibited cytokine production in LPS-stimulated CD14
+-THP-1 cells. 
Recently, it was clarified that THP-1 cells do not produce IL-8 under LPS- and PMA-stimulated 
conditions. On the other hand, CD14
+-THP-1 cells produced a high concentration of IL-8 under   
LPS-stimulated conditions. Therefore, we tested whether DDMG-1 dose-dependently inhibited IL-8 
production in LPS-stimulated CD14
+-THP-1 cells. The results indicated that DDMG-1 inhibited IL-8 
production by LPS-stimulated CD14
+-THP-1 cells (Figure 4a). Moreover, we examined whether 
DDMG-1 inhibits hTNF-α, hIL-1β, and hIL-6 production under the same experimental conditions as Mar. Drugs 2009, 7                                    
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for IL-8 production. The results shown in Figure 4a revealed that hTNF-α, hIL-1β, and hIL-6 
production was lower than that of IL-8, and DDMG-1 (10 μM) inhibited hTNF-α and hIL-6 
production, but the effect of DDMG-1 on IL-1β production was not determined. Evaluation of the 
influences of MTT solution on the cell survival rate revealed a decrease at a concentration of 10 μM, 
but we did not observe cell death using the LDH method (Figure 4b). Specifically, an inhibitory effect 
on cell proliferation was observed at a high concentration of DDMG-1. The result was judged not as 
cytotoxicity but as an inhibitory effect on cell proliferation. Only small amounts of hTNF-α, hIL-6, and 
hIL-1β were produced in this experimental system. The experimental data to examine the effect of 
DDMG-1 lack accuracy. The inhibitory effect of DDMG-1 seems to be weak. 
 
Figure 4. Effects of DDMG-1 on hTNF-α, hIL-8, hIL-6, and hIL-1β production and cell 
proliferation induced by LPS-stimulated CD14
+-THP-1 cells. (a) Effects of DDMG-1 on 
hTNF-α, hIL-8, hIL-6, and hIL-1β production in LPS-stimulated or non-stimulated 
CD14
+-THP-1 cells. CD14
+-THP-1 cells (1 × 10
6 cells/mL) were untreated or treated with 
LPS (1 μg/mL) at the indicated concentrations of compounds for 24 h. hTNF-α, hIL-8, 
hIL-6, and hIL-1β levels in the culture supernatant were measured by ELISA, as described 
in Materials and Methods. This experiment was repeated three times on different days. 
Figures were created based on the results. *p < 0.05 vs. Control; 
#p < 0.05 vs. LPS.   
(b) Effects of DDMG-1 on cell proliferation. MTT and LDH assays were conducted as 
described in Materials and Methods. Data are the mean values relative (%) to the control. 
 
 
Three  α-carboline alkaloids, grossularines-1 and -2 [7] and DDMG-1 [5], have thus far been 
isolated from ascidians. Grossularines-1 and -2 showed weak cytotoxicity against murine leukemia 
L1210 cells and were more cytotoxic to human colon (WiDr) and breast (MCF7) tumor cell lines [7,8]. 
The cytotoxic mechanisms of the two compounds were suggested to be different [8]. On the other 
hand, the biological activity of DDMG-1 has not been reported. DDMG-1 exhibited modest inhibitory 
activity against the colony formation of Chinese hamster V79 cells (EC50 = 10 μM) [9], and, in this 
study, we identified a new bioactivity in which DDMG-1 inhibited the production of mTNF-α from 
LPS-stimulated RAW264.7 cells by inhibiting IκB-α degradation and NF-κB binding to the target 
DNA.  Moreover, we demonstrated that IL-8 in the culture supernatant of LPS-stimulated   
CD14
+-THP-1 cells was also decreased by DDMG-1 treatment. Mar. Drugs 2009, 7                                    
 
 
595
The overexpression of TNF-α has been detected in chronic inflammatory diseases and, therefore, 
compounds that control the production of TNF-α will become drug candidates for the treatment of 
inflammatory diseases [10,11]. In rheumatoid arthritis, a variety of cell populations including 
macrophages infiltrate the tissue in large numbers, and a range of proinflammatory cytokines [IL-1, 
IL-6, and IL-8] are abundantly produced by them [12]. Moreover, it has been said that even 
tumorigenesis is caused by macrophage activation. Apart from these types of inflammation, 
macrophages are often observed in solid tumors, where they are called tumor-associated macrophages 
[13]. NF-κB is a transcription factor that promotes the transcription of genes of many proinflammatory 
cytokines. In macrophages, it is considered to regulate the production of IL-1, IL-6, IL-8, and TNF-α. 
NF-κB is activated by extracellular signals such as LPS, IL-1, and TNF-α.  Besides the existing 
activation route for NF-κB, a nonclassical pathway has recently been identified [14]. Our experiment 
using RAW264.7 cells demonstrated that, in TNF-α induction accompanied by activated NF-κB under 
LPS stimulation, reduced TNF-α in the culture supernatant due to DDMG-1 suppressed IκBα 
degradation, with resulting decreases in both the binding capacity of NF-κB to the target DNA and 
mRNA expression. Thus, DDMG-1 was demonstrated to reduce the inducibility. However, this study 
does not reveal whether the specific effect of DDMG-1 on NF-κB signaling is exerted directly or 
indirectly. In this regard, data from other experimental systems, such as a study on the effects of different 
stimuli using the same cell, are needed. Although the inhibitory activity of DDMG-1 against TNF-α 
production is not significant, DDMG-1, with its rare α-carboline structure, is a promising lead 
compound for the development of anti-TNF-α drugs. 
 
3. Experimental Section  
 
3.1. General 
 
1H- and 
13C-NMR spectra were recorded on a JEOL JNM-AL-400 NMR spectrometer at 400 MHz 
for 
1H and 100 MHz for 
13C in CD3OD (δH 3.30, δC 49.0). Mass spectra were obtained by a JEOL 
JMS-MS 700 mass spectrometer (EI mode). 
 
3.2. Isolation of DDMG-1 
 
The solitary ascidian P. aurata (2.2 kg, wet weight) was collected by scuba diving (–3~7 m) in the 
Lembeh Strait, Indonesia, in 2008, cut into small pieces, and soaked in ethanol. The ethanol extract 
was evaporated and the residue was dissolved in MeOH-H2O (4:1) and washed with n-hexane. The 
methanolic solution was concentrated and diluted with water to a MeOH content of 40%, and the 
solution was extracted with CHCl3. The CHCl3 extract (12.3 g) was subjected to chromatography on 
SiO2 with CHCl3-MeOH (gradient elution) to give six fractions. The fourth fraction (7:3 elution, 8.0 g) 
was separated by an ODS column (50, 70, 85, and 100% MeOH) into four fractions. The second 
fraction (70% MeOH elution, 0.6 g) was purified by HPLC (ODS, 70% MeOH) to yield 34.4 mg of 
DDMG-1. The structure of DDMG-1 is shown in Figure 1. 
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DDMG-1: yellow pigment; 
1H-NMR (CD3OD)  δ 9.34 (1H, s, H-2’), 8.47 (1H, m,   
H-4’), 8.23 (1H, d, J = 8.0 Hz, H-5), 7.48 (2H, m, H-8 and H-7’), 7.41 (1H, dd, J = 8.0, 8.0 Hz, H-7), 
7.23 (3H, m, H-6, H-5’, and H-6’); 
13C-NMR (CD3OD) δ 187.3 (C-13), 153.4 (C-11), 148.8 (C-2), 
141.8 (C-9), 138.9 (C-2’), 137.5 (C-8a), 135.9 (C-7a’), 131.8 (C-3), 128.9 (C-7), 128.7 (C-4), 124.3 
(C-3a’), 123.7 (C-5), 123.3 (C-4’), 123.2 (C-6’), 122.6 (C-5’), 121.3 (C-4b), 118.8 (C-6), 115.8 (C-3’), 
112.8 (C-7’), 112.4 (C-8), 103.5 (C-4a); EIMS m/z 366 (M
+, 100%), 249 [(M – indole)
+], 221   
[(M – indole-CO)
+]. 
 
3.3. Materials 
 
Fetal bovine serum (FBS) and other culture materials were purchased from Invitrogen (Carlsbad, 
CA, USA). Anti-actin was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). All 
other chemicals, including endotoxin LPS (Escherichia coli 055-85) and 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT), were purchased from Sigma-Aldrich (St. Louis, MO, USA).  
 
3.4. Cell culture 
 
RAW 264.7 cells were grown in culture medium (RPMI medium, containing 10% FBS, 2 mM 
glutamine, 100 U/mL of penicillin G and 100 μg/mL of streptomycin). THP1-Blue
TM-CD14  
(CD14
+-THP-1) cells were purchased from InvivoGen. The cells were maintained and subcultured in 
growth medium (RPMI medium) supplemented with 200 μg/mL Zeocin
TM and 10 μg/mL Blasticidin. 
These cells were cultured in humidified (5% CO2) incubator at 37 °C. 
 
3.5. Murine TNF-α (mTNF-α), murine IL-6 (mIL-6), human TNF-α (hTNF-α), human IL-β (hIL-β), 
human IL-6 (hIL-6), and human IL-8 (hIL-8) quantification 
 
RAW 264.7 cells or CD14
+-THP-1 cells were pretreated with DDMG-1 for 5 min. After LPS (final 
concentration: 1 μg/mL) was added, except to the control, experimental conditional cells were cultured 
for 24 h at 37 °C. The inflammatory cytokine concentration of each culture supernatant was measured 
using an ELISA kit following the manufacturer’s instructions (R&D Systems, Inc., Minneapolis, MN, 
USA).  
 
3.6. Measurement of TNF-α mRNA expression 
 
RAW264.7 cells (3 × 10
5 cells/35 mm dishes) were incubated with 5 or 10 μM of DDMG-1 for  
1 h, and then LPS(1 μg/mL) was added. After incubation for 4 hr, the cells were recovered and washed 
with PBS(-) twice. This is because the mRNA expression level was the highest at 4 h after stimulation. 
Total RNA was extracted with Sepasol-RNA I (Nacalai Tesque Co., Kyoto, Japan). SuperScript III 
(Invitrogen) was used to synthesize first-strand cDNAs from 1 μg total RNA using oligo-dT15 primers. 
PCR was performed using the QuantiTect SYBER Green PCR Master Mix (TOYOBO Co.) with an 
ABI 7300 real-time PCR system (Applied Biosystems). Primers for quantitative PCR (Q-PCR) were as 
follows: TNF-α sense primer: 5’-CCAAGGACACCCCTGAGGGGGC-3’, TNF-α antisense primer: Mar. Drugs 2009, 7                                    
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3’-TCACAGAGCAATGACTCTTGCCCG-5’, GAPDH sense primer; 5’-TTACTCCTTGGAGGCC-
ATGTAG-3’, GAPDH antisense primer: 3’-AATGACAACTTTGTCAAGCTCATT-5’. A thermal 
cycle of 95 ºC, 15 s; 60 ºC, 30 s; and 72 ºC, 30 s was repeated for 40 cycles. 
 
3.7. Western blot analysis 
 
RAW 264.7 cells were pretreated with DDMG-1 for 5 min and stimulated with LPS (1 μg/mL) for 
5–30 min. Cytoplasmic extracts of cells were subjected to Western blot analysis with anti-IκB 
antibody. The blots were finally reacted with ECL reagent (Amersham-Pharmacia, San Francisco, 
USA) and exposed to X-ray film [15].  
 
3.8. Cell viability assay and determination of cytotoxicity 
 
Lethal cell injury was assessed by measuring lactate dehydrogenase (LDH) release [16], while 
proliferation was evaluated by enumerating viable cells using the MTT formazan production method 
[17]. RAW 264.7 cells were incubated with various concentrations (0.1, 1, 3, and 10 μM) of DDMG-1 
for 24 h. The cells were treated with MTT solution and, after incubation for 3h, formazan production 
was assessed by measuring the OD (570 nm).  
 
3.9. Preparation of nuclear extracts and EMSA 
 
Nuclear extracts were prepared from RAW 264.7, cells as described previously [15], and aliquots 
were frozen at -80 °C. EMSA was conducted on 5% polyacrylamide gels in 1 × Tris-borate/EDTA 
electrophoresis buffer. mTNF-α/NFκ-B and AP-1 were synthesized by Rikaken (Aichi, Japan). The 
other experimental conditions were as described previously [15,18]. 
 
3.10. Statistical analysis 
 
Each experiment was performed at least three times, and representative data are shown. Means were 
checked for significant differences using Student’s t-test, with p-values of <0.05. 
 
4. Conclusions 
 
DDMG-1 inhibited the mRNA level of mTNF-α, IκB-α degradation, and binding of NF-κB to the 
target DNA site in LPS-stimulated RAW 264.7 cells. Moreover, DDMG-1 exhibited an inhibitory 
effect on IL-8 production, which is produced in CD14
+-THP-1 cells stimulated with LPS. DDMG-1, 
which has a rare α-carboline structure, is thus a promising drug candidates lead of for the treatment of 
chronic inflammatory diseases, such as rheumatoid arthritis. 
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